These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Discovery of new selective human aldose reductase inhibitors through virtual screening multiple binding pocket conformations. Wang L; Gu Q; Zheng X; Ye J; Liu Z; Li J; Hu X; Hagler A; Xu J J Chem Inf Model; 2013 Sep; 53(9):2409-22. PubMed ID: 23901876 [TBL] [Abstract][Full Text] [Related]
23. Merging the binding sites of aldose and aldehyde reductase for detection of inhibitor selectivity-determining features. Steuber H; Heine A; Podjarny A; Klebe G J Mol Biol; 2008 Jun; 379(5):991-1016. PubMed ID: 18495158 [TBL] [Abstract][Full Text] [Related]
24. Kinetics and molecular docking studies of an anti-diabetic complication inhibitor fucosterol from edible brown algae Eisenia bicyclis and Ecklonia stolonifera. Jung HA; Islam MN; Lee CM; Oh SH; Lee S; Jung JH; Choi JS Chem Biol Interact; 2013 Oct; 206(1):55-62. PubMed ID: 23994501 [TBL] [Abstract][Full Text] [Related]
25. Structure of aldehyde reductase in ternary complex with a 5-arylidene-2,4-thiazolidinedione aldose reductase inhibitor. Carbone V; Giglio M; Chung R; Huyton T; Adams J; Maccari R; Ottana R; Hara A; El-Kabbani O Eur J Med Chem; 2010 Mar; 45(3):1140-5. PubMed ID: 20036445 [TBL] [Abstract][Full Text] [Related]
26. Aldose reductase and its inhibition in the control of diabetic complications. Narayanan S Ann Clin Lab Sci; 1993; 23(2):148-58. PubMed ID: 8457142 [TBL] [Abstract][Full Text] [Related]
27. Exploring antidiabetic potential of adamantyl-thiosemicarbazones via aldose reductase (ALR2) inhibition. Shehzad MT; Hameed A; Al-Rashida M; Imran A; Uroos M; Asari A; Mohamad H; Islam M; Iftikhar S; Shafiq Z; Iqbal J Bioorg Chem; 2019 Nov; 92():103244. PubMed ID: 31541804 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of aldose reductase by dietary antioxidant curcumin: mechanism of inhibition, specificity and significance. Muthenna P; Suryanarayana P; Gunda SK; Petrash JM; Reddy GB FEBS Lett; 2009 Nov; 583(22):3637-42. PubMed ID: 19850041 [TBL] [Abstract][Full Text] [Related]
29. Search for non-acidic ALR2 inhibitors: Evaluation of flavones as targeted agents for the management of diabetic complications. Vyas B; Choudhary S; Singh PK; Kumar M; Verma H; Singh M; Malik AK; Silakari O Bioorg Chem; 2020 Mar; 96():103570. PubMed ID: 31978681 [TBL] [Abstract][Full Text] [Related]
30. Synthesis, activity, and molecular modeling of a new series of tricyclic pyridazinones as selective aldose reductase inhibitors. Costantino L; Rastelli G; Vescovini K; Cignarella G; Vianello P; Del Corso A; Cappiello M; Mura U; Barlocco D J Med Chem; 1996 Oct; 39(22):4396-405. PubMed ID: 8893834 [TBL] [Abstract][Full Text] [Related]
32. Addressing selectivity issues of aldose reductase 2 inhibitors for the management of diabetic complications. Kumar M; Choudhary S; Singh PK; Silakari O Future Med Chem; 2020 Jul; 12(14):1327-1358. PubMed ID: 32602375 [TBL] [Abstract][Full Text] [Related]
33. Synthesis, molecular modeling, selective aldose reductase inhibition and hypoglycemic activity of novel meglitinides. Salem MG; Abdel Aziz YM; Elewa M; Nafie MS; Elshihawy HA; Said MM Bioorg Chem; 2021 Jun; 111():104909. PubMed ID: 33895603 [TBL] [Abstract][Full Text] [Related]
34. Different effects of two aldose reductase inhibitors on nociception and prostaglandin E. Calcutt NA; Li L; Yaksh TL; Malmberg AB Eur J Pharmacol; 1995 Oct; 285(2):189-97. PubMed ID: 8566138 [TBL] [Abstract][Full Text] [Related]
35. Kinetic and structural effects of activation of bovine kidney aldose reductase. Grimshaw CE; Shahbaz M; Jahangiri G; Putney CG; McKercher SR; Mathur EJ Biochemistry; 1989 Jun; 28(13):5343-53. PubMed ID: 2550052 [TBL] [Abstract][Full Text] [Related]
36. Potential use of aldose reductase inhibitors to prevent diabetic complications. Zenon GJ; Abobo CV; Carter BL; Ball DW Clin Pharm; 1990 Jun; 9(6):446-57. PubMed ID: 2114249 [TBL] [Abstract][Full Text] [Related]
37. Oxidized aldose reductase: in vivo factor not in vitro artifact. Grimshaw CE; Lai CJ Arch Biochem Biophys; 1996 Mar; 327(1):89-97. PubMed ID: 8615700 [TBL] [Abstract][Full Text] [Related]
38. Exploration of thioxothiazolidinone-sulfonate conjugates as a new class of aldehyde/aldose reductase inhibitors: A synthetic and computational investigation. Andleeb H; Tehseen Y; Jabeen F; Khan I; Iqbal J; Hameed S Bioorg Chem; 2017 Dec; 75():1-15. PubMed ID: 28888096 [TBL] [Abstract][Full Text] [Related]
39. Kinetics and molecular docking studies of kaempferol and its prenylated derivatives as aldose reductase inhibitors. Jung HA; Moon HE; Oh SH; Kim BW; Sohn HS; Choi JS Chem Biol Interact; 2012 May; 197(2-3):110-8. PubMed ID: 22543015 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of aldose reductase activity by Cannabis sativa chemotypes extracts with high content of cannabidiol or cannabigerol. Smeriglio A; Giofrè SV; Galati EM; Monforte MT; Cicero N; D'Angelo V; Grassi G; Circosta C Fitoterapia; 2018 Jun; 127():101-108. PubMed ID: 29427593 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]